Clinical trial · Interventional
Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver
Effect of Preoperative Administration of Oral Pregabalin on the Postoperative Analgesia in Patients Scheduled for Radiofrequency Ablationof Focal Lesions in the Liver
NCT03151213CI-TRIAL-00105400pregabalincompletedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aimed to investigate the preemptive analgesia efficacy of of preemptive pregabalin for the postoperative pain management after radiofrequency ablation (RFA) of liver cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Cancer | Hepatocellular Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Placebo | Other | — | UNRESOLVED |
| Pregabalin 150mg | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Pregabalin
- description
- Pregabalin 150 mg before intervention
- interventionNames
- Drug: Pregabalin 150mg
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Placebo before intervention
- interventionNames
- Other: Placebo
Primary outcomes (1)
- measure
- visual analogue pain scale (VAS Pain) post operatively
- timeFrame
- 2 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * HCC patients, Child A, B, scheduled for Radiofrequency ablation of HCC. Exclusion Criteria: * Encephalopathy, Renal impairment
References
Publications (0)
Data not yet available
No reference posted for this study.